Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02454153 · ClinicalTrials.gov registry record · NA
Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy
A NA study of Diabetes and Sleep Apnea, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 184
- Enrollment target
- 1
- Study location
NCT02454153: Completed NA study of Diabetes and Sleep Apnea, sponsored by Johns Hopkins University.
NCT02454153 is a NA study of Diabetes and Sleep Apnea that has completed, run by Johns Hopkins University. The registered enrollment target is 184 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02454153, a NA study of Diabetes and Sleep Apnea, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized control trial in people with diabetes and obstructive sleep apnea who will be randomly assigned for 3 months to PAP therapy along with healthy lifestyle and sleep education or healthy lifestyle and sleep education.
Primary Outcome
Continuous Glucose Monitoring Metrics - change in standard deviation between baseline and three months.
Conditions Studied
Interventions
- DEVICE REMStar Positive Airway Pressure
- BEHAVIORAL LifeStyle Counseling
Study Locations (1)
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-03-15 |
| Phase | NA |
What the finished NCT02454153 record still lists
NCT02454153 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which REMStar Positive Airway Pressure is the first listed.
NCT02454153 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02454153 about?
NCT02454153 is a clinical study titled "Hyperglycemic Profiles in Obstructive Sleep Apnea: Effects of PAP Therapy". This is a randomized control trial in people with diabetes and obstructive sleep apnea who will be randomly assigned for 3 months to PAP therapy along with healthy lifestyle and sleep education or healthy lifestyle and sleep education.
What is the current status of trial NCT02454153?
This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2014-12. Estimated completion is 2020-03-15.
What conditions does trial NCT02454153 study?
This clinical trial studies the following conditions: Diabetes, Sleep Apnea.
What interventions are being tested in trial NCT02454153?
The interventions under investigation include: REMStar Positive Airway Pressure (DEVICE), LifeStyle Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02454153?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02454153 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02454153's enrollment target sits among peer trials
184 156th of 338 higher than 183 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia